News
In this retrospective cohort study, treatment with semaglutide resulted in nominally lower incidence of the composite of ...
Medically reviewed by Kristie Reed, PharmD Semaglutide is a medication mainly used to lower blood sugar levels in people with type 2 diabetes. However, it may also help manage weight due to its ...
Like in the STRIDE study of PAD, GLP-1s improved outcomes, but more work is needed to clarify who may benefit most.
A new study published in The Lancet journal showed that patients with type 2 diabetes and symptomatic peripheral arterial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results